INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2019

DHEA supplementation improved IVF/ICSI outcomes, including retrieved oocytes, pregnancy rate, and live birth rate, in women with DOR or POR.

A systematic review and meta-analysis of nine prospective RCTs involving 833 patients evaluated the efficacy of DHEA supplementation versus placebo during IVF or ICSI. DHEA treatment significantly increased the number of retrieved oocytes (mean difference: 0.91; 95% CI: 0.23-1.59; p = 0.009), the clinical pregnancy rate (RR: 1.27; 95% CI: 1.01-1.61; p = 0.04), and the live birth rate (RR: 1.76; 95% CI: 1.17-2.63; p = 0.006). No significant difference was observed for miscarriage rate (RR: 0.37; 95% CI: 0.12-1.13; p = 0.08).

Study type
Meta-analysis of randomized controlled trials
Who was studied
833 patients with diminished ovarian reserve and/or poor ovarian response undergoing IVF/ICSI (9 RCTs)
What was measured
Retrieved oocytes, clinical pregnancy rate, live birth rate, and miscarriage rate

THE PAPER

The Effect of Dehydroepiandrosterone (DHEA) Supplementation on IVF or ICSI: A Meta-Analysis of Randomized Controlled Trials.

Xu L, Hu C, Liu Q, Li Y. Geburtshilfe Frauenheilkd, 2019.

PubMed 31303658 ↗DOI 10.1055/a-0882-3791 ↗

Other health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.